DataInsightsOur ThinkingWhitepaper March 23, 2023 Protected: Disease landscapes: Meaningful scientific and strategic assessments for drug discovery and development There is no excerpt because this is a protected post. Nagendran P Love0
BlogsDataOur Thinking March 9, 2023 ChEMBL vs. GOSTAR – Data diversity and compound coverage Two of the most popular sources of data for building predictive models are GOSTAR and… Nagendran P Love0
BlogsClinical Data ServicesDataInsightsOur Thinking March 9, 2023 A day in the life of a clinical pharmacology expert Clinical pharmacologists understand that drug development is a complex and time-consuming activity. Let’s explore how… Nagendran P Love0
DataInsightsOur ThinkingWhitepaper February 28, 2023 Selecting and preparing data for AI/ML predictive modeling Find out the impact of data selection on the predictive accuracy of AI/ML models and… Nagendran P Love0
BlogsDataInsightsOur Thinking February 8, 2023 The role of key opinion leaders in accelerating COVID-19 vaccine use In this blog, we discuss the development of COVID-19 vaccines and the role of KOLs… Nagendran P Love0
BlogsDataInsights February 7, 2023 Choosing the appropriate ontology management system for your research An ontology management system (OMS) is a toolkit to support the building, application, and maintenance… Nagendran P Love0
Our ThinkingWhitepaper January 16, 2023 Optimizing scRNA-seq data analysis with effective pipeline development Single-cell RNA sequencing (scRNA-seq) allows genetic makeup to be studied at the level of single… Nagendran P Love0
BlogsData January 6, 2023 Make better, faster drug development decisions with analysis-ready clinical datasets R&D teams need clinical data quickly available and effectively digitized to support critical decision-making milestones… Nagendran P Love0
BlogsDataInsights December 20, 2022 Why you need key opinion leaders (KOLs) in your medical device marketing strategy In this blog post, we’ll discuss the importance of KOLs and thought leaders in marketing… Nagendran P Love0
DataFeaturedInsightsR&D TechnologyWhitepaper October 20, 2022 Accelerating discovery and creating value Pharmas and biotechs are united by a common goal: discovery. Whether seeking new treatments, improved… Ben.frew@excelra.com Love0